PALI-2108 clinical trials

A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's Disease

This study looks at a new drug, PALI-2108, for people with a type of Crohn's disease that causes narrowing (fibrostenotic Crohn's). We want to understand how it works in the body to help with inflammation and scarring.